Gartland M, Wang X, Liao Q, Li B, et al. Exploring the impact of baseline and on-treatment variables on durability of responses to fostemsavir through weeks 96 and 192 in the phase 3 BRIGHTE study. HIV Med 2025 Dec 12. doi: 10.1111/hiv.70154.
PMID: 41387279